Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death

NeuroToxicology

Volumn 29, Issue 4, 2008, Pages 656-662

  Cho, Hong Suk ^a   Kim, Seung ^a   Lee, Sook Young ^a   Park, Jeong Ae ^a   Kim, Sung Jun ^a   Chun, Hong Sung ^a  

^a Chosun University   (South Korea)

Author keywords

Dieldrin; l Theanine; Rotenone; SH SY5Y

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN TEA EXTRACT; HEME OXYGENASE 1; LEVO THEANINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTOXIN;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; APOPTOSIS; CELL LINE, TRANSFORMED; DIELDRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLUTAMATES; HEME OXYGENASE-1; HUMANS; INDOLES; INSECTICIDES; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; ROTENONE;

EID: 46149085627     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2008.03.004     Document Type: Article

References (40)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12 (1997) 25-31
2. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
3. Chen C.N., Liang C.M., Lai J.R., Tsai Y.J., Tsay J.S., and Lin J.K. Capillary electrophoretic determination of theanine, caffeine, and catechins in fresh tea leaves and oolong tea and their effects on rat neurosphere adhesion and migration. J Agric Food Chem 51 (2003) 7495-7503
4. Chun H.S., Son J.J., and Son J.H. Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease. Neuroreport 11 (1999) 511-514
5. Chun H.S., Gibson G.E., DeGiorgio L.A., Zhang H., Kidd V.J., and Son J.H. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76 (2001) 1010-1021
6. Chung W., Miranda C.L., and Maier C.S. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Res 1176 (2007) 133-142
7. Corrigan F.M., Wienburg C.L., Shore R.F., Daniel S.E., and Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 59 (2000) 229-234
8. Egashira N., Hayakawa K., Mishima K., Kimura H., Iwasaki K., and Fujiwara M. Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice. Neurosci Lett 363 (2004) 58-61
9. Ewing J.F., and Maines M.D. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc Natl Acad Sci USA 88 (1991) 5364-5368
10. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97 (2000) 2875-2880
11. Howells D.W., Porritt M.J., Wong J.Y., Batchelor P.E., Kalnins R., Hughes A.J., et al. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 166 (2000) 127-135
12. Hsuan S., Klintworth H.M., and Xia Z. Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. J Neurosci 26 (2006) 4481-4491
13. Jenner P., and Olanow C.W. Understanding cell death in Parkinson's disease. Ann Neurol 44 3 Suppl 1 (1998) S72-S84
14. Kakuda T., Yanase H., Utsunomiya K., Nozawa A., Unno T., and Kataoka K. Protective effect of gamma-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils. Neurosci Lett 289 (2000) 189-192
15. Kakuda T. Neuroprotective effects of the green tea components theanine and catechins. Biol Pharm Bull 25 (2002) 1513-1518
16. Kakuda T., Nozawa A., Sugimoto A., and Nino H. Inhibition by theanine of binding of [3H]AMPA, [3H]kainite, and [3H]MDL 105, 519 to glutamate receptors. Biosci Biotechnol Biochem 66 (2002) 2683-2686
17. Kanthasamy A.G., Kitazawa M., Kanthasamy A., and Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology 26 (2005) 701-719
18. Keeney P.M., Xie J., Capaldi R.A., and Bennett Jr. J.P. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26 (2006) 5256-5264
19. Kim Y.S., Zhuang H., Koehler R.C., and Dore S. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. Free Radic Biol Med 38 (2005) 85-92
20. Kimura K., Ozeki M., Juneja L.R., and Ohira H. l-Theanine reduces psychological and physiological stress responses. Biol Psychol 74 (2007) 39-45
21. Nagatsu T., and Sawada M. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm Suppl 72 (2007) 113-120
22. Newhouse K., Hsuan S.L., Chang S.H., Cai B., Wang T., and Xia Z. Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci 79 (2004) 137-146
23. Nimura T., Weinstein P.R., Massa S.M., Panter S., and Sharp F.R. Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Brain Res Mol Brain Res 37 (1996) 201-208
24. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22 (1999) 123-144
25. Parfenova H., Basuroy S., Bhattacharya S., Tcheranova D., Qu Y., Regan R.F., et al. Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol 290 (2006) C1399-C1410
26. Peng C., Fan S., Li X., Fan X., Ming M., Sun Z., et al. Overexpression of pitx3 upregulates expression of BDNF and GDNF in SH-SY5Y cells and primary ventral mesencephalic cultures. FEBS Lett 581 (2007) 1357-1361
27. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7 (2008) 97-109
28. Schipper H.M., Liberman A., and Stopa E.G. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150 (1998) 60-68
29. Schroeter H., Boyd C., Spencer J.P., Williams R.J., Cadenas E., and Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23 (2002) 861-880
30. Shamoto-Nagai M., Maruyama W., Kato Y., Isobe K., Tanaka M., Naoi M., et al. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 74 (2003) 589-597
31. Sherer T.B., Richardson J.R., Testa C.M., Seo B.B., Panov A.V., Yagi T., et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem 100 (2007) 1469-1479
32. Siegel G.J., and Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 33 (2000) 199-227
33. Singh C., Ahmad I., and Kumar A. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress. Cell Mol Biol 53 (2007) 19-28
34. Son J.H., Chun H.S., Joh T.H., Cho S., Conti B., and Lee J.W. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci 19 (1999) 10-20
35. Tooyama I., Kawamata T., Walker D., Yamada T., Hanai K., Kimura H., et al. Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology 43 (1993) 372-376
36. Yamada T., Terashima T., Wada K., Ueda S., Ito M., Okubo T., et al. γ-Glutamylethylamide, increases neurotransmission concentrations and neurotrophin mRNA levels in the brain during lactation. Life Sci 81 (2007) 1247-1255
37. Yokogoshi H., Kato Y., Sagesaka Y.M., Takihara-Matsuura T., Kakuda T., and Takeuchi N. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci Biotechnol Biochem 59 (1995) 615-618
38. Yokogoshi H., Kobayashi M., Mochizuki M., and Terashima T. Effect of theanine, gamma-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res 23 (1998) 667-673
39. Yokogoshi H., Mochizuki M., and Saitoh K. Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechnol Biochem 62 (1998) 816-817
40. Zhang J., and Piantadosi C.A. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 90 (1992) 1193-1199